These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 17139376

  • 1. A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury.
    Frank RD, Holscher T, Schabbauer G, Tencati M, Pawlinski R, Weitz JI, Mackman N.
    Thromb Haemost; 2006 Dec; 96(6):802-6. PubMed ID: 17139376
    [Abstract] [Full Text] [Related]

  • 2. The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia-reperfusion injury.
    Frank RD, Schabbauer G, Holscher T, Sato Y, Tencati M, Pawlinski R, Mackman N.
    J Thromb Haemost; 2005 Mar; 3(3):531-40. PubMed ID: 15748244
    [Abstract] [Full Text] [Related]

  • 3. Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats.
    Olanders K, Börjesson A, Zhao X, Andersson R.
    Acta Anaesthesiol Scand; 2005 Apr; 49(4):517-24. PubMed ID: 15777300
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
    Furuichi K, Wada T, Iwata Y, Kokubo S, Hara A, Yamahana J, Sugaya T, Iwakura Y, Matsushima K, Asano M, Yokoyama H, Kaneko S.
    Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
    [Abstract] [Full Text] [Related]

  • 5. The synthetic pentasaccharide fondaparinux prevents coronary microvascular injury and myocardial dysfunction in the ischemic heart.
    Montaigne D, Marechal X, Lancel S, Decoster B, Asseman P, Neviere R.
    Thromb Haemost; 2008 Nov; 100(5):912-9. PubMed ID: 18989538
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC.
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blockade of p-selectin reduces neutrophil infiltration into the murine testis after ischemia-reperfusion-injury.
    Celebi M, Paul AG.
    Dtsch Tierarztl Wochenschr; 2008 Dec; 115(12):457-60. PubMed ID: 19113028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of Toll-like receptor (TLR) 2 and 9 in renal ischemia and reperfusion injury.
    Li X, Yun Z, Tan Z, Li S, Wang D, Ma K, Chi N, Liu J, Chen F, Gao G.
    Urology; 2013 Jun; 81(6):1379.e15-20. PubMed ID: 23541229
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serine protease inhibitor aprotinin ameliorates renal injury in a rat model of ischemia-perfusion injury.
    Altan H, Bozkurt AK, Arslan C, Ustundag N, Konukoglu D, Koksal C.
    Transplant Proc; 2009 Jun; 41(5):1512-6. PubMed ID: 19545668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.